GCNT1
Basic information
Region (hg38): 9:76419850-76651203
Previous symbols: [ "NACGT2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GCNT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 2 | 1 |
Variants in GCNT1
This is a list of pathogenic ClinVar variants found in the GCNT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-76502401-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
9-76502424-A-C | not specified | Uncertain significance (Jun 18, 2021) | ||
9-76502472-G-A | not specified | Uncertain significance (Jul 13, 2022) | ||
9-76502508-G-T | not specified | Uncertain significance (Feb 16, 2023) | ||
9-76502545-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
9-76502565-G-A | not specified | Likely benign (Dec 18, 2023) | ||
9-76502700-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
9-76502742-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
9-76502760-A-C | not specified | Uncertain significance (May 17, 2023) | ||
9-76502769-C-A | not specified | Uncertain significance (Jun 04, 2024) | ||
9-76502866-A-G | not specified | Uncertain significance (Apr 09, 2024) | ||
9-76502919-A-C | not specified | Uncertain significance (Jun 09, 2022) | ||
9-76502935-T-C | not specified | Uncertain significance (Jun 10, 2022) | ||
9-76502955-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
9-76503048-A-G | not specified | Uncertain significance (Dec 28, 2023) | ||
9-76503084-T-C | Benign (Mar 30, 2018) | |||
9-76503176-G-A | Likely benign (Jul 01, 2022) | |||
9-76503406-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
9-76503468-G-A | not specified | Uncertain significance (Mar 29, 2024) | ||
9-76503496-G-A | not specified | Uncertain significance (May 31, 2022) | ||
9-76503540-G-A | not specified | Uncertain significance (Oct 20, 2023) | ||
9-76503549-T-C | not specified | Uncertain significance (Feb 22, 2023) | ||
9-76503594-G-T | not specified | Uncertain significance (May 24, 2023) | ||
9-76503630-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
9-76619356-A-T | not specified | Uncertain significance (Feb 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GCNT1 | protein_coding | protein_coding | ENST00000442371 | 1 | 87581 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00333 | 0.955 | 125693 | 0 | 54 | 125747 | 0.000215 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.791 | 201 | 235 | 0.855 | 0.0000131 | 2857 |
Missense in Polyphen | 73 | 96.931 | 0.75311 | 1212 | ||
Synonymous | -0.189 | 91 | 88.7 | 1.03 | 0.00000523 | 800 |
Loss of Function | 1.78 | 6 | 12.9 | 0.466 | 7.20e-7 | 165 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000214 | 0.000213 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000405 | 0.000404 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Glycosyltransferase that catalyzes the transfer of an N- acetylglucosamine moiety onto mucin-type core 1 O-glycan to form the branched mucin-type core 2 O-glycan. Mucin-type core 2 O- glycans play an important role in leukocyte extravasation as they serve as scaffolds for the display of the selectin ligand sialyl Lewis X by leukocytes. {ECO:0000269|PubMed:23027862}.;
- Pathway
- Mucin type O-glycan biosynthesis - Homo sapiens (human);Globo Sphingolipid Metabolism;Post-translational protein modification;Metabolism of proteins;mucin core 1 and core 2 <i>O</i>-glycosylation;O-Glycan biosynthesis;O-linked glycosylation of mucins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.159
Intolerance Scores
- loftool
- 0.658
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 75.43
Haploinsufficiency Scores
- pHI
- 0.0924
- hipred
- Y
- hipred_score
- 0.507
- ghis
- 0.405
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.294
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gcnt1
- Phenotype
- normal phenotype; hematopoietic system phenotype; digestive/alimentary phenotype; immune system phenotype; renal/urinary system phenotype; cellular phenotype;
Gene ontology
- Biological process
- glycoprotein biosynthetic process;O-glycan processing;response to insulin;tissue morphogenesis;leukocyte tethering or rolling;cell adhesion molecule production;kidney morphogenesis
- Cellular component
- Golgi membrane;extracellular space;trans-Golgi network;integral component of membrane;Golgi cisterna
- Molecular function
- beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity;protein binding